Clinical relevance of transient worsening renal function after initiation of sacubitril/valsartan.
Daniele MasaroneEnrico MelilloVittoria ErrigoFabio ValenteGiuseppe PacileoPublished in: Current medical research and opinion (2020)
WRF occurs in nearly 30% of HFrEF patients without impacting clinical outcomes; HF specialists should be aware of these changes to avoid unnecessary discontinuation of sacubitril/valsartan therapy.